Latest News

Nov 18, 2019

Propanc Biopharma Advances POP1 Drug Discovery Program

Propanc Developing Backup Synthetic Compound to Lead Product Candidate, PRP MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical…

View All Press Releases